Hamish Ryder

Hamish Ryder, Director of Discovery, Cancer Research Technology.

Hamish obtained his first degree in natural sciences and a PhD in organic chemistry from the University of Cambridge. He then spent 10 years working in the pharma/biotech industry in the UK as a medicinal scientist. He moved to Spain in 1996 as Director of Drug Discovery at Almirall, Spain's largest pharmaceutical company. In January 2008 he returned to the UK, joining CRT as Director of Drug Discovery. Hamish has worked in a number of therapeutic areas, including autoimmunity and inflammation, respiratory, GI, CNS and cancer, and with multiple target classes. He has led teams and overseen organisations that have produced over 25 candidate drugs for regulatory development, resulting in one approved drug to date (Bretaris).